Introduction
The infection of hepatitis B virus is still considered as one of the leading public health problems in the world. According to the recent data of WHO, there are about 240 millions of individuals have been exposed to the chronic hepatitis B infection worldwide. The incidence of hepatitis B varies according to the geographical regions and they are classified as high, medium and low
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Objective: The aim of the study was to show the progress of hepatitis B seropositivity rates of pregnant women in Turkey for the last two decades by regions and years and to evaluate the current condition in consideration of the studies published.
Methods:
The studies investigating hepatitis B seropositivity of pregnant women in Turkey were analyzed by reviewing the databases and the literature. On this topic, 64 studies performed between 1975 and 2016 were found. The studies published within the last 2 decades (1996-2016) were arranged by their publication years. Additionally, the data of the women delivered in our clinic between 2012 and 2015 were reviewed retrospectively and the result of HBsAg seropositivity rate was determined.
endemic regions. According to this classification, Turkey is among the medium endemic regions.
Hepatitis B virus seropositivity is evaluated with hepatitis B surface antigen (HBsAg) and HBsAg seropositivity rate is 5% in women in the world which varies between 0.6 and 20% according to the endemic regions. [1] Hepatitis B virus (HBV) is transmitted by body fluids such as infectious blood, saliva and vaginal fluid/semen or percutaneous or mucosal contact. On the other hand, perinatal contagion is blamed particularly in the high endemic regions. Infection contagion from HBsAg positive mother to baby can occur during intrauterine, intrapartum or postpartum period. While contagion during intrauterine period is rare, it is more frequent during intrapartum or postpartum period when baby may contact with infected maternal fluids.
It was found that hepatitis B e antigen (HBeAg) and serum HBV DNA levels of mother are effective in the contagion of the infection from HBV carrier mother to the baby during perinatal period. [2] It was reported in a study that the risk of contagion from mothers negative for HBeAg was 10-40% and that the risk increases to 70-90% in positive women. [3] When it is transmitted from mothers positive for HBeAg, it is considered that the rate of the disease being chronic in the infected baby also increases. [4] Thanks to the active and passive immunization applied together with the birth, the risk of contagion to babies born from mothers positive for HBsAg/HBeAg is decreased. In Turkey, all newborns have been vaccinated routinely for hepatitis B since 1998.
As the perinatal contagion of hepatitis B is still important today, we aimed in this study to explain the seropositivity of hepatitis B virus of pregnant women in the light of the studies carried out in Turkey and to show the progress of HBsAg seropositivity rate by regions and years.
Methods
The studies on HBV seropositivity in pregnant women were screened in the databases of ULAKBIM Medical Database (Turkish Medical Index), TürkMedline and Turkish Citation Index. The studies were researched by using the keywords "hepatit B" (hepatitis B), "HBsAg", "gebe enfeksiyon" (infection in pregnant women), "gebe hepatit B" (hepatitis B in pregnant women), and "gebe HBsAg" (HBsAg in pregnant women). Other studies were found by analyzing the studies found in the databases. Except the theses published in Turkey, the theses found during the database investigation were reviewed in terms of the literature. On this topic, 64 studies performed between 1975 and 2016 were found. The studies performed within the last 2 decades (1996-2016) were arranged by their publication years ( Table 1) .
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Bakar RZ, Dane B 84 Çepni [9] 1996 Istanbul 4078 4.4 Kuru [10] 1996 Istanbul 5366 4.2 Kadanal› [11] 1997 Erzurum 282 6.3 Kaleli [12] 1997 Denizli 312 7.7 Ak›n [13] 1997 Bursa 310 5.5 Gül [14] 1998 Van 98 4.08 Biri [15] 2001 Ankara 451 7 Aslan [16] 2001 fianl›urfa 450 4.6 Yücel [17] 2001 Ankara 644 3.2 Sa¤söz [18] 2002 K›r›kkale 157 4.9 Karaca [19] 2003 Istanbul 460 4.7 Yegane Tosun [20] 2003 Izmir 760 4.2 Harma [21] 2003 fianl›urfa 136 7.3 Y›lmazer [22] 2004 Afyon 244 2.9 Tekay [23] 2006 fianl›urfa 2335 5.1 Madenda¤ [24] 2007 Ankara 90351 2.1 Çakmak [25] 2008 Ni¤de 4831 1.2 S›rmatel [26] 2008 Gaziantep 397 9.3 Uyar [27] 2009 Samsun 2654 2.1 At›lgan [28] 2009 Rize 1130 2.56 Dündar [29] 2009 Istanbul 3503 2.2 Kölgelier [30] 2009 Ad›yaman 660 4.7 Api [31] 2009 Istanbul 228 3.9 Alt›nbafl [32] 2010 Ankara 4700 2.8 Köksald› Motor [33] 2010 Hatay 5410 1.5 Akdemir [34] 2010 Ankara 1422 1.2 Karl›da¤ [35] 2011 Elaz›¤ 5120 1.9 Coflkun [36] 2011 Istanbul 795 3.7 Araz [37] 2011 Gaziantep 11840 2.1 Gönen [38] 2011 Düzce 1028 3.3 Varol [39] 2011 Edirne 1526 3 Deveci [40] 2011 Mardin 1570 2.9 Çopur Çiçek [41] 2012 fianl›urfa 56275 3.5 Kölgelier [3] 2012 Ad›yaman 9420 4.7 Çakmak [42] 2012 Kocaeli 3756 2.2 Y›ld›z [43] 2012 Diyarbak›r 2900 2.66 Özlü [44] 2013 Bolu 653 1.8 Bal›k [45] 2013 Rize 5894 5.7 Koruk [46] 2013 fianl›urfa 261 3.2 Do¤an [47] 2014 Istanbul 2011 1.2 Özcan Da¤ [48] 2015 K›r›kkale 8442 3.47 Ayn›o¤lu [49] 2015 Zonguldak 1084 4
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Hepatitis B seropositivity of pregnant women and the review of Turkish literature 85 Additionally, the data of the women delivered in our clinic between 2012 and 2015 were reviewed retrospectively and the result of HBsAg seropositivity rate was determined in our study.
Results
There are more than 60 studies, investigating HBsAg seropositivity of pregnant women in Turkey, performed in different years and in the same and different cities. While these studies show that HBsAg seropositivity varies between 1.2 and 19.2% in Turkey, no higher positivity was found in other studies after the study reporting the rate as 19.2%. It is seen that the highest rate reported by the studies performed within the last two decades is 9.3% ( Table 1) . It is seen that the rate is less than 6% in the studies performed in the last 7 years with the contribution of vaccine program carried out throughout the country.
In our study that we investigated the rate of HBsAg seropositivity of pregnant women, we found this rate as 2.16% in 4037 pregnant women. In the study, we retrospectively analyzed the data of pregnant women who delivered at our clinic between 2012 and 2015 and found that 8.22% of the pregnant women were of foreign nationality, the mean age was 28.64 (±5.77), mean week of gestation was 38.57 (±2.72), gravida was 2.51 (±1.44) and parity was 1.20 (±1.16).
Discussion
Hepatitis B virus is an infectious agent which progress with mortality and may cause chronic liver diseases, cirrhosis and hepatocellular carcinoma. HBV is transmitted essentially by infected blood and body fluids as well as percutaneous or mucosal contact. On the other hand, perinatal contagion is blamed particularly for the incidence of hepatitis B in the high endemic regions. The presence of this infection is important in terms of obstetrics as it is considered that HBV infection has adverse effects on gestational outcomes. Infection contagion from carrier mother to baby can occur during intrauterine, intrapartum or postpartum period. It is thought that the reasons such as skin scars, mucosal penetration, swallowing maternal blood and fetomaternal bleeding due to placental injury have a role in the intrapartum contagion. [5] There are many studies in the literature investigating the effects of HBV infection on gestational outcomes. In a study, it was reported that preterm labor rate is higher in pregnant women positive for HBsAg than the pregnant women in the control group and that the rates of gestational diabetes, preterm labor and low birth weight are higher in carrier women positive for HBsAg than the carrier women negative for HBsAg. [6] In another study, it is claimed that HBsAg seropositivity is associated with antepartum hemorrhage and low APGAR scores. [7] There are more than 60 studies, investigating HBsAg seropositivity of pregnant women in Turkey, performed in different years and in the same and different cities. While these studies show that HBsAg seropositivity is between 1.2 and 19.2% in Turkey, the study of Turhano¤lu et al. in 1987 which was conducted on pregnant women in Diyarbak›r found the rate 19.2% [8] and no such positivity has been seen in all other studies published afterwards. [8] When we evaluate the studies performed in the last two decades ( Table 1) , we see that the highest rate is 9.3%. [26] It is seen that HBsAg seropositivity rate is lower in the studies performed with high number of pregnant women than those with less number of pregnant women. In the first three studies with the highest pregnant woman population, the rates of HBsAg seropositivity were 2.1% (90,351 pregnant women), [24] 3.5% (56,275 pregnant women) [41] and 2.1% (11,840 pregnant women). [37] It is remarkable in this regard that the numbers of pregnant women in studies with the rate above 7% are 397, 312 and 136. [26, 12, 21] The variety among the rates of HBsAg positivity in the studies shown in Table 1 may have many reasons. While some of these studies were carried out in reference centers such as university and training and research hospitals, some of them were performed in rural areas and maternal-pediatric health centers. [38, 13] In this regard, it should be remembered that the studies carried out in the clinics which are reference centers cannot reflect the entire society. The rates also vary by regions and years. In recent years, HBsAg seropositivity rates tend to decrease in pregnant women as in the general population. With the help of country-wide vaccination program which has been conducted since 1998, no HBsAg seropositivity over 6% has been found in the studies carried out in the last 7 years.
In the studies investigating perinatal contagion, cord blood of babies of HBsAg seropositive mothers was checked and while a study found 45% HBsAg seropositivity in cord blood, [50] another study found no
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HBsAg seropositivity in the cord blood. [40] Kuru et al. [51] conducted screenings on the children as well as husbands of HBsAg seropositive cases and they found antiHbs rate over 20%. In the same study, there was no statistically significant difference between seropositive and seronegative cases in terms of age, number of pregnancy, socioeconomical status, intravenous injection, and applying blood and blood products.
We found the rate of HBsAg seropositivity of pregnant women in our clinic 2.16% in 4037 pregnant women. In this study, we retrospectively analyzed the data of pregnant women who delivered at our clinic between 2012 and 2015, and investigated HBsAg results checked with ELISA method in the peripheral blood samples collected routinely from the pregnant women at antenatal period. Of the pregnant women, 8.22% were foreign. Of those included in the study, mean age was 28.64 (±5.77), mean week of gestation was 38.57 (±2.72), gravida was 2.51 (±1.44) and parity was 1.20 (±1.16). We found that the HBsAg seropositivity rate in our clinic was consistent with the rates found in similar studies conducted in Istanbul in recent years.
When we look at the Table 1 which shows the progress of HBsAg seropositivity in different cities within last 20 years, we see that the rate is slightly above 4% in Istanbul for the first 10 years while it decreases to the level below 4% in the last 10 years. Although the rate reported in the study of Do¤an et al. published in 2014 decreases to 1.2%, [47] the reasons for the slight increase in our study are considered to be the increased migration to Istanbul from other cities and the Middle East, and our clinic being one of the reference centers.
When we look at the distribution among the reasons, we see that there is a clear decrease in HBsAg seropositivity of pregnant women in Marmara, Mediterranean/Aegean and Eastern Anatolia regions while the rates fluctuate in Central and Southeastern Anatolia regions. On the other hand, the rate in Black Sea region increased from 2.2% to 5.1% in the last 10 years (Fig. 1) . This result shows that further studies are required to investigate the reasons for the increase in Black Sea region.
Conclusion
As perinatal contagion maintains its importance in the endemic regions, it is necessary to investigate HBV of pregnant women in these regions and to take protective precautions against this infection. In Turkey, it is fought against the perinatal contagion of HBV by antenatal HBsAg screening, routine HBV vaccine of newborns and passive and active immunization practices applied on newborns of the mothers who are positive for HBsAg. In addition, high risk groups are vaccinated against HPV and with all these methods, it is expected to decrease the rate of hepatitis B in future years in Turkey.
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